Roxana Drake, MD, PhD from Novartis will give a presentation on January 29, 2016 from 09:00 to 10:00 EST (15:00-16:00 CET) entitled Clofazimine – repurpose & strategy.
The presentation will focus on the current status of clofazimine and on its development as a multidrug-resistant TB drug. The study design and rationale for clofazimine dose selection will be presented.
Click here for instructions on how to connect.